查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
dPCR 和 qPCR 市场规模和预测、全球和地区份额、趋势以及按治疗、产品、应用、最终用户和地理位置进行的成长机会分析
市场调查报告书
商品编码
1389606

dPCR 和 qPCR 市场规模和预测、全球和地区份额、趋势以及按治疗、产品、应用、最终用户和地理位置进行的成长机会分析

dPCR and qPCR Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment, Product, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 159 Pages | 订单完成后即时交付

价格

dPCR和qPCR市场规模预计将从2022年的89.76亿美元成长到2030年的182.30亿美元；预计2022-2030年CAGR为9.3%。

dPCR 和 qPCR 市场的成长归因于遗传性疾病和传染病发病率的增加、基因合成投资和资金的增加以及 PCR 技术的技术进步。

近年来，PCR 等分子方法已发展成为诊断技术。此方法使医疗保健专业人员能够准确诊断多种传染病，被认为是不可或缺的研究和诊断工具。 PCR 允许从一条 DNA 链产生数百万个 DNA 拷贝。它还可以实现疾病的早期诊断，因此在疾病控制中发挥重要作用。 PCR 可提供不同实验室之间具有可比性的可重复结果，因此在全世界范围内得到认可。随着PCR技术在新兴国家被广泛接受和使用。根据世界卫生组织2016年关于在发展中国家建立PCR实验室的报告，世卫组织正在提供必要的技术援助，以便在世卫组织东南亚国家的所有11个成员国建立PCR实验室。这些实验室将有助于提供高品质的医疗服务。这些PCR实验室根据需要采用了不同的PCR技术，例如逆转录酶PCR（RT-PCR）、多重PCR、即时PCR、原位PCR、数位PCR（dPCR）等。由于其简单、快速和高度特异性的疾病筛检及其在临床微生物学、病毒学、寄生虫学、生物技术和相关领域的日益增长的应用，预计发展中国家的dPCR 和qPCR 市场将在预测期内经历利润丰厚的机会。

微滴式数位 PCR (ddPCR) 是一种进行数位 PCR 的新技术。它采用水油乳化液滴技术。待测样品被分成约20,000个液滴，然后在每个液滴中进行目标DNA链的扩增。然后 ddPCR 以数位方式测量单一液滴中的核酸目标。因此，该技术可以对目标 DNA 分子进行高精度和绝对定量，并在诊断和研究中广泛应用。在 qPCR 中，DNA 定量是根据循环阈值 (CT) 获得的。需要外部校准器，且不完美的扩增会影响绝对定量。微滴式数位 PCR (ddPCR) 直接对目标 DNA 进行计数，无需校准曲线。因此，随着 ddPCR 的出现，科学家将能够探索复杂的遗传景观，发现和验证新的疾病关联，并定义分子诊断的新时代。因此，ddPCR的发展将成为未来dPCR和qPCR市场的一大趋势。

基于应用程式的见解

根据应用，dPCR 和 qPCR 市场分为研究应用、临床应用和法医应用。 2022年，临床应用领域占最大市场份额，预计2022-2030年CAGR最高。分子生物学技术彻底改变了疾病诊断，现已成为实验室诊断的重要组成部分。 dPCR 和 qPCR 技术现已用于许多疾病的诊断，包括糖尿病、传染病、癌症等。例如，即时PCR技术RIDA GENE试剂盒是为诊断胃肠道感染、院内感染(HAI)、呼吸道感染、性传染感染和其他参数而开发的。由于这些分子方法可以进行早期、敏感和特异性的诊断，因此临床应用领域预计将在预测期内出现成长。

即时PCR技术已被用来检测基因突变，这有助于癌症的诊断。 dPCR 也能够精确检测痰、尿液、脑脊髓液、血浆等无细胞 DNA (cfDNA) 样本中的肿瘤标记。 dPCR 在检测野生型序列中的单核苷酸多态性方面更有效。例如，dPCR 通常用于检测表皮生长因子受体 (EGFR)、KRAS 和 ESR1 的突变。

此外，技术进步为诊断和治疗癌症提供了分子标记。 2023 年 4 月，赛默飞世尔科技为其 QuantStudio Dx 系列仪器推出了 37 种带有 CE-IVD 标记的即时 PCR 检测试剂盒，用于检测多种传染病。

基于最终用户的见解

根据最终用户，dPCR 和 qPCR 市场分为医院和诊断中心、製药和生物技术公司、研究实验室和学术机构、法医实验室和临床研究组织。 2022年，医院和诊断中心细分市场占据最大市场份额，预计2022-2030年CAGR最高。

医院和诊断中心为 dPCR 和 qPCR 市场贡献了重要的市场份额。医院是病患在训练有素的人员指导下寻求先进治疗的主要中心。 dPCR 和 qPCR 具有高灵敏度和特异性等优点，可以早期且准确地检测病原体，包括细菌、病毒和真菌。

此外，医院为患者提供先进的诊断和治疗选择，以治疗急性和慢性疾病，医院和诊断中心对PCR技术的采用率要高得多，因为它们为医疗机构提供了专门的科学设备。此外，新兴国家医疗保健基础设施的持续扩张、传染病的高发生率以及住院人数的不断增加，催生了对快速、灵敏的诊断工具的需求。此外，对早期有效的疾病诊断和治疗的需求不断增长，用于诊断应用的dPCR 产品数量不断增加，dPCR 在疾病诊断中提供的优势（与其他PCR 技术相比），以及公众对其益处的认识不断增强这些用于临床和疾病诊断的技术推动了市场的成长。

此外，诊断实验室配备了精良的高科技设备，可轻鬆实现各种待测试样品的工作流程和管理。例如，Thermo Fisher Scientific, Inc. 提供多种 PCR 变体，包括 QuantStudio 5、QuantStudio 6 Flex、QuantStudio 7、QuantStudio 12k、QuantStudio 3D 和 QuantStudio Absolute Q AutoRun dPCR Suite。同样，Bio-Rad Laboratories, Inc.、Fluidigm Corporation、Eppendorf 和 A​​gilent Technologies, Inc. 等多家公司根据医院和诊断中心的能力和要求向其提供 PCR 设备。

疾病管制与预防中心、医学研究未来基金和世界卫生组织 (WHO) 是准备 dPCR 和 qPCR 市场报告时参考的主要和次要来源。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：dPCR 与 qPCR 市场模式

  • 概述
  • PEST分析
    • 全球PEST分析

第 5 章：dPCR 和 qPCR 市场 - 主要产业动态

  • 市场驱动因素
    • 遗传性疾病和传染病的发生率增加
    • 基因合成的投资和资金不断增加
    • PCR 技术的技术进步
  • 市场限制
    • PCR 系统的高成本
    • 与 qPCR 相关的技术限制
  • 市场机会
    • 新兴国家越来越多地采用 PCR 方法
  • 未来的趋势
    • 微滴式数位PCR的发展
  • 影响分析：

第 6 章：dPCR 和 qPCR 市场 - 全球市场分析

  • dPCR 和 qPCR 市场收入，2022 - 2030

第 7 章：全球 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按治疗方式

  • 概述
  • 2022 年和 2030 年按治疗方式分類的 dPCR 和 qPCR 市场收入份额 (%)
  • 定量PCR
  • 数位PCR

第 8 章：全球 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 2022 年和 2030 年按产品分類的 dPCR 和 qPCR 市场收入份额 (%)
  • 试剂及耗材
  • 仪器
  • 软体与服务

第 9 章：全球 dPCR 和 qPCR 市场 - 收入和 2030 年预测 -按应用

  • 概述
  • 2022 年和 2030 年按应用分類的 dPCR 和 qPCR 市场收入份额 (%)
  • 研究应用
  • 临床应用
  • 法医应用

第 10 章：全球 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年按最终用户分類的 dPCR 和 qPCR 市场收入份额 (%)
  • 医院和诊断中心
  • 製药和生物技术公司
  • 研究实验室和学术机构
  • 法医实验室
  • 临床研究组织

第 11 章：dPCR 和 qPCR 市场 - 地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：dPCR 和 qPCR 市场-产业格局

  • 概述
  • dPCR 和 qPCR 市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 13 章：公司简介

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Standard BioTools Inc
  • Lepu Medical Technology Beijing Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc
  • Genome Diagnostics Pvt Ltd

第 14 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPHE100000817

The dPCR and qPCR market size is expected to grow from US$ 8.976 billion in 2022 to US$ 18.230 billion by 2030; it is estimated to record a CAGR of 9.3% during 2022-2030.

The dPCR and qPCR market growth is attributed to the increasing incidence of genetic and infectious diseases, rising investments and funds for gene synthesis, and technological advancements in PCR technologies.

In recent years, molecular methods such as PCR have evolved as diagnostic technology. The method enables healthcare professionals to diagnose a wide range of infectious diseases accurately and is considered an indispensable research and diagnostic tool. PCR allows the generation of millions of DNA copies from one single strand of DNA. It also allows early diagnosis of disease and hence plays an essential role in disease control. PCR gives reproducible results that are comparable between different laboratories and hence are accepted worldwide. As PCR techniques are being widely accepted and utilized in emerging countries. According to the World Health Organization Report on the Establishment of PCR Laboratory in Developing Countries 2016, WHO is providing necessary technical assistance to establish PCR laboratories in all 11 member states of the WHO South East Asia countries. The laboratories will help in providing high-quality medical care. These PCR laboratories have adopted different PCR technologies such as Reverse transcriptase PCR (RT-PCR), Multiplex PCR, Real-time PCR, In-situ PCR, Digital PCR (dPCR), and others depending on their need. Due to its simple, rapid, and highly specific screening of diseases and its increasing application in clinical microbiology, virology, parasitology, biotechnology, and allied fields, the dPCR and qPCR market in developing countries is expected to experience lucrative opportunities during the forecast period.

Droplet Digital PCR (ddPCR) is a new technique for performing digital PCR. It utilizes water-oil emulsion droplet technology. A sample to be tested is fractionated into around 20,000 droplets, and then amplification of the target DNA strand is carried out in each droplet. The ddPCR then digitally measures the nucleic acid targets in the individual droplet. Thus, the technique gives high precision and absolute quantification of target DNA molecules and enables wide application in diagnosis and research. In qPCR, DNA quantification is obtained from the cycle threshold (CT). External calibrators are required, and imperfect amplification affects absolute quantitation. Droplet Digital PCR (ddPCR) directly counts the target DNA without the calibration curve. Thus, with the advent of ddPCR, scientists will be able to explore complex genetic landscapes, discover and validate new disease associations, and define a new era of molecular diagnostics. Thus, the development of ddPCR would become a major trend in the dPCR and qPCR market in the future.

Application-Based Insights

Based on application, the dPCR and qPCR market is segmented into research application, clinical application, and forensic application. In 2022, the clinical application segment held the largest share of the market and is anticipated to register the highest CAGR during 2022-2030. Molecular biology techniques have revolutionized disease diagnosis and are now a crucial part of laboratory diagnostics. The dPCR and qPCR techniques are now being used in the diagnosis of many diseases, including diabetes, infectious diseases, cancer, and others. For instance, real-time PCR technology RIDA GENE kits are developed for the diagnosis of gastrointestinal infections, hospital-acquired infections (HAI), respiratory infections, sexually transmitted infections, and other parameters. As these molecular methods allow early, sensitive, and specific diagnosis, the clinical application segment is expected to witness growth over the forecast period.

Real-time PCR technologies have been used to detect mutation in genes, which helps in the diagnosis of cancer. dPCR also enables precise detection of tumor markers in cell-free DNA (cfDNA) samples like sputum, urine, cerebrospinal fluid, plasma, and others. dPCR is more effective in detecting single-nucleotide polymorphism among the wild-type sequences. For example, dPCR is commonly used to detect mutation in epidermal growth factor receptor (EGFR), KRAS, and ESR1.

Furthermore, technological advancements are offering molecular markers for diagnosing and treating cancer. In April 2023, Thermo Fisher Scientific introduced 37 CE-IVD-marked real-time PCR assay kits for its QuantStudio Dx series of instruments to detect numerous infectious diseases.

End User-Based Insights

Based on end user, the dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. In 2022, the hospitals and diagnostic centers segment held the largest share of the market and is anticipated to register the highest CAGR during 2022-2030.

Hospitals and diagnostic centers contribute a significant market share to the dPCR and qPCR market. Hospitals are the primary centers for a patient seeking highly advanced treatment under the guidance of much-trained personnel. dPCR and qPCR offer advantages such as high sensitivity and specificity, allowing early and accurate detection of pathogens, including bacteria, viruses, and fungi.

In addition, hospitals offer advanced diagnosis and treatment options for patients to treat acute and chronic conditions, and the adoption of PCR techniques is much higher in hospitals and diagnostic centers as they provide healthcare facilities with specialized scientific equipment. Moreover, the continued expansion of healthcare infrastructure across emerging countries, the high incidences of infectious diseases, and the growing number of hospital admissions has created a need for rapid and sensitive diagnostic tools. Additionally, growing demand for early and efficient disease diagnosis and treatment, the increasing number of dPCR product launches for diagnostic applications, the advantages offered by dPCR in disease diagnosis (as compared to other PCR technologies), and growing awareness among public associated with the benefits offered by both these technologies for clinical and disease diagnosis fuel the market growth.

Furthermore, diagnostic laboratories are well-equipped with hi-tech equipment that enables easy workflow and management of various samples to be tested. For instance, Thermo Fisher Scientific, Inc. offers multiple variants of its PCR, including QuantStudio 5, QuantStudio 6 Flex, QuantStudio 7, QuantStudio 12k, QuantStudio 3D, and QuantStudio Absolute Q AutoRun dPCR Suite. Similarly, several companies, such as Bio-Rad Laboratories, Inc., Fluidigm Corporation, Eppendorf, and Agilent Technologies, Inc., offer PCR devices to hospitals and diagnostic centers based on their capacity and requirements.

Centers for Disease Control and Prevention, Medical Research Future Fund, and the World Health Organization (WHO) are among the primary and secondary sources referred to while preparing the dPCR and qPCR market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the dPCR and qPCR market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global dPCR and qPCR market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global dPCR and qPCR market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interests with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. dPCR and qPCR Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. dPCR and qPCR Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidence of Genetic and Infectious Diseases
    • 5.1.2 Rising Investments and Funds for Gene Synthesis
    • 5.1.3 Technological Advancements in PCR Technologies
  • 5.2 Market Restraints
    • 5.2.1 High Costs of PCR Systems
    • 5.2.2 Technical Limitations Associated with qPCR
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of PCR Methods in Emerging Countries
  • 5.4 Future Trends
    • 5.4.1 Development of Droplet Digital PCR
  • 5.5 Impact Analysis:

6. dPCR and qPCR Market - Global Market Analysis

  • 6.1 dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

7. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

  • 7.1 Overview
  • 7.2 dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 7.3 Quantitative PCR
    • 7.3.1 Overview
    • 7.3.2 Quantitative PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Digital PCR
    • 7.4.1 Overview
    • 7.4.2 Digital PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

  • 8.1 Overview
  • 8.2 dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • 8.3 Reagents & Consumables
    • 8.3.1 Overview
    • 8.3.2 Reagents & Consumables: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Instruments
    • 8.4.1 Overview
    • 8.4.2 Instruments: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Software & Services
    • 8.5.1 Overview
    • 8.5.2 Software & Services: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

  • 9.1 Overview
  • 9.2 dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • 9.3 Research Application
    • 9.3.1 Overview
    • 9.3.2 Research Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Clinical Application
    • 9.4.1 Overview
    • 9.4.2 Clinical Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.1 dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
  • 9.5 Forensic Application
    • 9.5.1 Overview
    • 9.5.2 Forensic Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

  • 10.1 Overview
  • 10.2 dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 10.3 Hospitals and Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Diagnostic Centers: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Pharmaceutical and Biotechnology Companies
    • 10.4.1 Overview
    • 10.4.2 Pharmaceutical and Biotechnology Companies: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Research Laboratories and Academic Institutes
    • 10.5.1 Overview
    • 10.5.2 Research Laboratories and Academic Institutes: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Forensic Laboratories
    • 10.6.1 Overview
    • 10.6.2 Forensic Laboratories: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.7 Clinical Research Organizations
    • 10.7.1 Overview
    • 10.7.2 Clinical Research Organizations: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

11. dPCR and qPCR Market - Geographical Analysis

  • 11.1 North America dPCR and qPCR Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.3 North America: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.1.4 North America: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.1.5 North America: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.1.5.1 North America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.1.6 North America: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.6.1 North America dPCR and qPCR Market, by Country
      • 11.1.6.2 US
        • 11.1.6.2.1 US dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.2.2 US: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.6.2.3 US: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.6.2.4 US: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.6.2.4.1 US: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.6.2.5 US: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.6.3 Canada
        • 11.1.6.3.1 Canada dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.3.2 Canada: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.6.3.3 Canada: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.6.3.4 Canada: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.6.3.4.1 Canada: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.6.3.5 Canada: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.6.4 Mexico
        • 11.1.6.4.1 Mexico dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.4.2 Mexico: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.6.4.3 Mexico: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.6.4.4 Mexico: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.6.4.4.1 Mexico: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.6.4.5 Mexico: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  • 11.2 Europe dPCR and qPCR Market, Revenue and Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.2.4 Europe: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.2.5 Europe: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.2.5.1 Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.2.6 Europe: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.1 Europe dPCR and qPCR Market, by Country
      • 11.2.6.2 UK
        • 11.2.6.2.1 UK dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.2.2 UK: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.2.3 UK: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.2.4 UK: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.2.4.1 UK: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.2.5 UK: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.3 Germany
        • 11.2.6.3.1 Germany dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.3.2 Germany: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.3.3 Germany: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.3.4 Germany: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.3.4.1 Germany: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.3.5 Germany: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.4 France
        • 11.2.6.4.1 France dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.4.2 France: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.4.3 France: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.4.4 France: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.4.4.1 France: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.4.5 France: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.5 Italy
        • 11.2.6.5.1 Italy dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.5.2 Italy: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.5.3 Italy: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.5.4 Italy: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.5.4.1 Italy: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.5.5 Italy: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.6 Spain
        • 11.2.6.6.1 Spain dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.6.2 Spain: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.6.3 Spain: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.6.4 Spain: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.6.4.1 Spain: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.6.5 Spain: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.7 Rest of Europe
        • 11.2.6.7.1 Rest of Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.7.2 Rest of Europe: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.7.3 Rest of Europe: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.7.4 Rest of Europe: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.7.4.1 Rest of Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.7.5 Rest of Europe: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  • 11.3 Asia Pacific dPCR and qPCR Market, Revenue and Forecast to 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.3 Asia Pacific: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.3.4 Asia Pacific: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.3.5 Asia Pacific: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.3.5.1 Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.3.6 Asia Pacific: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.1 Asia Pacific dPCR and qPCR Market, by Country
      • 11.3.6.2 China
        • 11.3.6.2.1 China dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.2.2 China: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.2.3 China: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.2.4 China: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.2.4.1 China: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.2.5 China: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.3 Japan
        • 11.3.6.3.1 Japan dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.3.2 Japan: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.3.3 Japan: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.3.4 Japan: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.3.4.1 Japan: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.3.5 Japan: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.4 India
        • 11.3.6.4.1 India dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.4.2 India: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.4.3 India: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.4.4 India: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.4.4.1 India: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.4.5 India: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.5 Australia
        • 11.3.6.5.1 Australia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.5.2 Australia: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.5.3 Australia: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.5.4 Australia: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.5.4.1 Australia: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.5.5 Australia: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.6 South Korea
        • 11.3.6.6.1 South Korea dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.6.2 South Korea: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.6.3 South Korea: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.6.4 South Korea: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.6.4.1 South Korea: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.6.5 South Korea: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.7 Rest of Asia Pacific
        • 11.3.6.7.1 Rest of Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.7.2 Rest of Asia Pacific: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.7.3 Rest of Asia Pacific: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.7.4 Rest of Asia Pacific: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.7.4.1 Rest of Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.7.5 Rest of Asia Pacific: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  • 11.4 Middle East & Africa dPCR and qPCR Market, Revenue and Forecast to 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.4.4 Middle East & Africa: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.4.5 Middle East & Africa: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.4.5.1 Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.4.6 Middle East & Africa: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.4.6.1 Middle East & Africa dPCR and qPCR Market, by Country
      • 11.4.6.2 Saudi Arabia
        • 11.4.6.2.1 Saudi Arabia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.2.2 Saudi Arabia: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.4.6.2.3 Saudi Arabia: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.4.6.2.4 Saudi Arabia: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.4.6.2.4.1 Saudi Arabia: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.4.6.2.5 Saudi Arabia: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.4.6.3 UAE
        • 11.4.6.3.1 UAE dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.3.2 UAE: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.4.6.3.3 UAE: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.4.6.3.4 UAE: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.4.6.3.4.1 UAE: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.4.6.3.5 UAE: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.4.6.4 South Africa
        • 11.4.6.4.1 South Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.4.2 South Africa: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.4.6.4.3 South Africa: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.4.6.4.4 South Africa: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.4.6.4.4.1 South Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.4.6.4.5 South Africa: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.4.6.5 Rest of Middle East & Africa
        • 11.4.6.5.1 Rest of Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.5.2 Rest of Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.4.6.5.3 Rest of Middle East & Africa: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.4.6.5.4 Rest of Middle East & Africa: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.4.6.5.4.1 Rest of Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.4.6.5.5 Rest of Middle East & Africa: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  • 11.5 South & Central America dPCR and qPCR Market, Revenue and Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.5.4 South & Central America: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.5.5 South & Central America: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.5.5.1 South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.5.6 South & Central America: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.5.6.1 South & Central America dPCR and qPCR Market, by Country
      • 11.5.6.2 Brazil
        • 11.5.6.2.1 Brazil dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.2.2 Brazil: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.5.6.2.3 Brazil: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.5.6.2.4 Brazil: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.5.6.2.4.1 Brazil: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.5.6.2.5 Brazil: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.5.6.3 Argentina
        • 11.5.6.3.1 Argentina dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.3.2 Argentina: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.5.6.3.3 Argentina: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.5.6.3.4 Argentina: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.5.6.3.4.1 Argentina: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.5.6.3.5 Argentina: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.5.6.4 Rest of South & Central America
        • 11.5.6.4.1 Rest of South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.4.2 Rest of South & Central America: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.5.6.4.3 Rest of South & Central America: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.5.6.4.4 Rest of South & Central America: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.5.6.4.4.1 Rest of South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.5.6.4.5 Rest of South & Central America: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

12. dPCR and qPCR Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in dPCR and qPCR Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Thermo Fisher Scientific Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Takara Bio Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Qiagen NV
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Standard BioTools Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Lepu Medical Technology Beijing Co Ltd
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 F. Hoffmann-La Roche Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Bio-Rad Laboratories Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Agilent Technologies Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Genome Diagnostics Pvt Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 SWOT Analysis
    • 13.10.5 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. dPCR and qPCR Market Segmentation
  • Table 2. dPCR and qPCR Market, by Clinical Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Canada dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Canada dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Mexico dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Mexico dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Mexico dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Mexico dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Mexico dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. UK dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. UK dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. UK dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. UK dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. UK dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Germany dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Germany dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Germany dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Germany dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Germany dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. France dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. France dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. France dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. France dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. France dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Italy dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Italy dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Italy dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. Italy dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Italy dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Spain dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Spain dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Spain dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. Spain dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. Spain dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Rest of Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Rest of Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Rest of Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Rest of Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Rest of Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. China dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. China dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. China dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. China dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. China dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Japan dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Japan dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Japan dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Japan dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Japan dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. India dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. India dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. India dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. India dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. India dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. Australia dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. Australia dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. Australia dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. Australia dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Australia dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. South Korea dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. South Korea dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. South Korea dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. South Korea dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. South Korea dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. Rest of Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. Rest of Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. Rest of Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Middle East & Africa dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Middle East & Africa dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. Middle East & Africa dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. Middle East & Africa dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. Saudi Arabia dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Saudi Arabia dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. Saudi Arabia dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. Saudi Arabia dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. Saudi Arabia dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. UAE dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. UAE dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. UAE dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. UAE dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. UAE dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. South Africa dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. South Africa dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. South Africa dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 111. South Africa dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 112. South Africa dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 113. Rest of Middle East & Africa dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 114. Rest of Middle East & Africa dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 115. Rest of Middle East & Africa dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 116. Rest of Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 117. Rest of Middle East & Africa dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 118. South & Central America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 119. South & Central America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 120. South & Central America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 121. South & Central America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 122. South & Central America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 123. Brazil dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 124. Brazil dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 125. Brazil dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 126. Brazil dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 127. Brazil dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 128. Argentina dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 129. Argentina dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 130. Argentina dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 131. Argentina dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 132. Argentina dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 133. Rest of South & Central America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 134. Rest of South & Central America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 135. Rest of South & Central America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 136. Rest of South & Central America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 137. Rest of South & Central America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 138. Recent Organic Growth Strategies in dPCR and qPCR Market
  • Table 139. Recent Inorganic Growth Strategies in the dPCR and qPCR Market
  • Table 140. Glossary of Terms, dPCR and qPCR Market

List Of Figures

  • Figure 1. dPCR and qPCR Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. dPCR and qPCR Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. dPCR and qPCR Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 7. dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 8. Quantitative PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Digital PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • Figure 11. Reagents & Consumables: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Instruments: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Software & Services: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 15. Research Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Clinical Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Forensic Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 19. Hospitals and Diagnostic Centers: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Pharmaceutical and Biotechnology Companies: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Research Laboratories and Academic Institutes: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Forensic Laboratories: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Clinical Research Organizations: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: dPCR and qPCR Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. North America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 27. US dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Canada dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Mexico dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Europe dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 31. Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Europe dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 33. UK dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Germany dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. France dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Italy dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Spain dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Rest of Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Asia Pacific dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 40. Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Asia Pacific dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 42. China dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Japan dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 44. India dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Australia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. South Korea dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Rest of Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. Middle East & Africa dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 49. Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. Middle East & Africa dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 51. Saudi Arabia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. UAE dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 53. South Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Rest of Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. South & Central America dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 56. South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. South & Central America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 58. Brazil dCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Argentina dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 60. Rest of South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Growth Strategies in dPCR and qPCR Market